Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Porter

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Epilepsia|October 4, 2012
Addressing the need for new therapies for epilepsyRoger J Porter
Epilepsy Research|December 3, 2016
The photosensitivity model is not a model for partial (focal) seizuresRoger J Porter
Epilepsy Research|December 4, 2016
The photosensitivity model is not a model for partial (focal) seizures-REBUTTALRoger J Porter
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
New antiepileptic drugs--discovery, development, and updateRoger J Porter, Jacqueline A French
Neurochemical Research|March 10, 2017
The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and BeyondRoger J Porter, Harvey J Kupferberg
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
RetigabineRoger J Porter, Virinder Nohria, Chris Rundfeldt
Epilepsy Research|March 30, 2010
Clinical development of drugs for epilepsy: a review of approaches in the United States and EuropeRoger J Porter, Michel Baulac, Virinder Nohria
International Journal of Clinical Pharmacology and Therapeutics|November 20, 2014
Mechanisms of action of anti-seizure drugs and the anticonvulsant screening program of the National Institute of Neurological Disorders and StrokeRoger J Porter, Harvey J Kupferberg, Bettie Jean Hessie
Handbook of Clinical Neurology|September 4, 2012
Mechanisms of action of antiseizure drugsRoger J Porter, Ashish Dhir, Robert L Macdonald, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical developmentRajesh Sachdeo, Arnaud Partiot, Victor Biton, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Epilepsia|October 4, 2012
Addressing the need for new therapies for epilepsyRoger J Porter
Epilepsy Research|December 3, 2016
The photosensitivity model is not a model for partial (focal) seizuresRoger J Porter
Epilepsy Research|December 4, 2016
The photosensitivity model is not a model for partial (focal) seizures-REBUTTALRoger J Porter
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
New antiepileptic drugs--discovery, development, and updateRoger J Porter, Jacqueline A French
Neurochemical Research|March 10, 2017
The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and BeyondRoger J Porter, Harvey J Kupferberg
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
RetigabineRoger J Porter, Virinder Nohria, Chris Rundfeldt
Epilepsy Research|March 30, 2010
Clinical development of drugs for epilepsy: a review of approaches in the United States and EuropeRoger J Porter, Michel Baulac, Virinder Nohria
International Journal of Clinical Pharmacology and Therapeutics|November 20, 2014
Mechanisms of action of anti-seizure drugs and the anticonvulsant screening program of the National Institute of Neurological Disorders and StrokeRoger J Porter, Harvey J Kupferberg, Bettie Jean Hessie
Handbook of Clinical Neurology|September 4, 2012
Mechanisms of action of antiseizure drugsRoger J Porter, Ashish Dhir, Robert L Macdonald, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical developmentRajesh Sachdeo, Arnaud Partiot, Victor Biton, et al.
Pageof 2